Exploring the differences in mortality and its associated factors among young-old and old-old COVID-19 patients
- PMID: 40809415
- PMCID: PMC12343559
- DOI: 10.3389/fmed.2025.1608667
Exploring the differences in mortality and its associated factors among young-old and old-old COVID-19 patients
Abstract
Background: This study aims to compare the differences in mortality and related factors between old-old and young-old COVID-19 patients and find unique factors related to survival in old-old patients.
Study design: Single-center retrospective cohort study following STROBE guidelines.
Methods: We included 302 elderly (≥65 years old) COVID-19 patients admitted to Shijiazhuang People's Hospital from December 1, 2022 to March 31, 2023. Among them, 142 were assigned to the young-old group (65-74 years old) and 160 in the old-old group (≥75 years old). Demographic, clinical and laboratory data were extracted, and descriptive statistical analysis, comparison of differences between groups, Cox proportional hazards regression analysis, and subgroup analysis were adopted.
Results: Compared with the young-old group, the mortality of old-old patients was higher (31.3% vs. 12.7%, p < 0.001). Risk factors associated with mortality specifically in old-old patients include dyspnea (HR: 2.829, 95%CI: 1.571-5.093), acute cardiac injury (HR: 2.403, 95%CI: 1.369-4.219), and diabetes (HR: 2.401, 95%CI: 1.311-4.397), glucocorticoid therapy (HR: 2.397, 95%CI: 1.198-4.798). Moreover, there was a significant difference in the survival curves between the young-old and the old-old group (p = 0.0001). However, no significant sex differences in mortality and survival curves were found in either group.
Conclusion: This study found for the first time that dyspnea symptoms, acute heart injury, diabetes, and glucocorticoid therapy are unique risk factors related to survival in old-old patients with COVID-19. These factors need more attention when treating old-old patients to prevent poor prognosis.
Keywords: COVID-19; mortality; older adults; retrospective study; risk factors.
Copyright © 2025 Zhong, Huang, Zhang, Tian, Zhang and Song.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Systemic treatments for metastatic cutaneous melanoma.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2. Cochrane Database Syst Rev. 2018. PMID: 29405038 Free PMC article.
-
[Association between obesity and the risk of microvascular complications in Yinzhou District, Ningbo adults with type 2 diabetes mellitus].Wei Sheng Yan Jiu. 2025 Jul;54(4):608-620. doi: 10.19813/j.cnki.weishengyanjiu.2025.04.012. Wei Sheng Yan Jiu. 2025. PMID: 40695761 Chinese.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.Cochrane Database Syst Rev. 2015 Feb 19;2015(2):CD000535. doi: 10.1002/14651858.CD000535.pub3. Cochrane Database Syst Rev. 2015. PMID: 25695213 Free PMC article.
References
-
- WHO WHO Covid-19 dashboard. WHO; (2024). Available online at: https://data.who.int/dashboards/covid19/deaths?n=o (accessed Aug 18, 2024)
-
- Tejeswini CJ, Syed J, Pereira P, Pankaja SS, Shwethashree MS, Basavanagowdappa H. Covid in oldest old: what we learnt in a tertiary care hospital emergency. Arch Gerontol Geriatr. (2024) 1:100019. doi: 10.1016/j.aggp.2024.100019 - DOI
LinkOut - more resources
Full Text Sources